文献速递神经肿瘤

简易免疫组化细胞比色测定法在垂体腺瘤预后评估中的应用研究

Study of Simple Immunohistochemical Cytocolorimetric Assay Application for More Accurate Assessment of Prognosis in Patients with Pituitary Adenomas.
PubMed 文献 · World Neurosurg · 2018-11-09

回顾性、盲法、随机、比较研究,采用传统Ki-67标记指数与自建简易免疫组化细胞比色分析(ICI)评估垂体腺瘤Ki-67表达活性对复发的预测价值。无复发组与复发组Ki-67标记指数差异无统计学意义,而ICI差异有统计学意义;ICI值与复发前时间的相关系数为-0.302,呈弱负相关。

要点

  • 无复发组与复发组Ki-67标记指数差异无统计学意义。
  • 无复发组与复发组Ki-67 ICI差异有统计学意义。
  • ICI值与复发前时间相关系数为-0.302,呈弱负相关。

核心结论

  • 成功测试了自建ICI法评估垂体腺瘤Ki-67表达,该技术可作为复发预后因素,并可与现代蛋白质组学和遗传学方法结合作为构建新多模态分析系统的基础。

研究设计与样本

  • 回顾性、盲法、随机、比较研究,采用传统Ki-67标记指数与自建简易免疫组化细胞比色分析(ICI)评估垂体腺瘤Ki-67表达活性对复发的预测价值。

主要发现

  • 无复发组平均Ki-67标记指数为3.87%±0.29%,复发组为4.01%±0.29%,差异无统计学意义。
  • 无复发组平均Ki-67 ICI为24.16%±0.51%,复发组为30.68%±0.64%,差异有统计学意义。
  • ICI值与复发前时间的相关系数为-0.302,呈弱负相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunohistochemistry is a basic diagnostic technique. Immunohistochemical examination results reflect mainly qualitative and less quantitative characteristics of proteomic status of cells. A combined approach with complex quantitative evaluation of marker expression using colorimetric analysis and computer technologies can expand the diagnostic capabilities of immunohistochemistry. We studied such an approach developed by using expression of the proliferative marker Ki-67 in pituitary adenomas. METHODS: A retrospective, blind, randomized, comparative study was performed of Ki-67 expression activity in pituitary adenomas using the traditional Ki-67 labeling index and a simple immunohistochemical cytocolorimetric analysis developed by us with immunohistochemical cytocolorimetric index (ICI) estimation as predictors of relapse, assessing the relationships of these indicators with the time before relapse. RESULTS: Mean Ki-67 labeling index was 3.87% ± 0.29% in the relapse-free group and 4.01% ± 0.29% in the relapse group; the difference was not statistically significant. The average Ki-67 ICI was 24.16% ± 0.51% in the relapse-free group and 30.68% ± 0.64% in the relapse group; the difference was statistically significant. The correlation coefficient of ICI values and time before relapse was -0.302, indicating the presence of a weak negative correlation. CONCLUSIONS: We successfully tested an ICI estimation method developed by us to assess Ki-67 expression in pituitary adenomas. The ICI technique can be used both as a prognostic factor for relapse and, in combination with other modern proteomic and genetic methods, as the basis for creation of new multimodal analyzing systems for functional state assessment of cells and tissues.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Nikitin PV, Ryzhova MV, Shishkina LV, et al. Study of Simple Immunohistochemical Cytocolorimetric Assay Application for More Accurate Assessment of Prognosis in Patients with Pituitary Adenomas. World Neurosurg. 2018. PMID: 30415039. doi:10.1016/j.wneu.2018.10.225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。